| RS1057515463 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057515531 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 1, Chronic infantile neurological |
| RS1057515534 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057515536 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057515537 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057515556 |
PPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1057515571 |
PMS2
|
Health Risk |
Pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS1057515572 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mismatch repair cancer syndrome 4, Lynch syndrome 4 |
| RS1057515573 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1057515574 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1057515575 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1057515576 |
ARL6
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 3, Bardet-Biedl syndrome 3 |
| RS1057515577 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1057515579 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057515580 |
KLHL24
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Koebner type |
| RS1057515581 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS1057515582 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS1057515583 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS1057515584 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS1057515585 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1057515614 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
TJP2-related disorder, TJP2-related disorder |
| RS1057515622 |
TMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 36, Autosomal recessive nonsyndromic hearing loss 7 |
| RS1057515645 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1057515654 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1057515672 |
PSAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
PSAT deficiency, Neu-Laxova syndrome 2 |
| RS1057515721 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 7, Gorlin syndrome |
| RS1057515724 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1057515767 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked mitochondrial encephalomyopathy, Inborn genetic diseases |
| RS1057515807 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
VACTERL association, X-linked |
| RS1057515818 |
TAFAZZIN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, 3-Methylglutaconic aciduria type 2 |
| RS1057515839 |
SMPX
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing loss, X-linked 4 |
| RS1057515869 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 3B, Duchenne muscular dystrophy |
| RS1057515877 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1057515971 |
ALAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked sideroblastic anemia 1, X-linked sideroblastic anemia 1 |
| RS1057515989 |
ABCB7
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked sideroblastic anemia with ataxia, X-linked sideroblastic anemia with ataxia |
| RS1057516028 |
DMD
|
Health Risk |
Pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS1057516029 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1057516030 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1057516031 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1057516032 |
ATP1A3
|
Health Risk |
Likely pathogenic |
ATP1A3-associated neurological disorder, ATP1A3-associated neurological disorder |
| RS1057516033 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS1057516034 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1057516035 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1057516036 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS1057516037 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS1057516038 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Joubert syndrome 23 |
| RS1057516039 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS1057516040 |
NALCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital contractures of the limbs and face, hypotonia |
| RS1057516041 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1057516042 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Aortic valve disease 2 |
| RS1057516043 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS1057516044 |
ABCC9
|
Health Risk |
Likely pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Hypertrichotic osteochondrodysplasia Cantu type |
| RS1057516045 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Pelger-Huët anomaly, 6 conditions |
| RS1057516046 |
ACTG2
|
Health Risk |
Pathogenic |
Visceral myopathy 1, Visceral myopathy 1 |
| RS1057516047 |
TTC7A
|
Health Risk |
Pathogenic |
Multiple gastrointestinal atresias, Multiple gastrointestinal atresias |
| RS1057516048 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1057516049 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1057516051 |
DYSF
|
Health Risk |
Pathogenic |
Proximal muscle weakness, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1057516052 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1057516053 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS1057516054 |
MKKS
|
Health Risk |
Likely pathogenic |
McKusick-Kaufman syndrome, McKusick-Kaufman syndrome |
| RS1057516076 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1057516077 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516079 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516080 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1057516081 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516082 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516083 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516085 |
KCNQ2
|
Health Risk |
Pathogenic |
Severe intellectual deficiency, Developmental and epileptic encephalopathy |
| RS1057516086 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516087 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516089 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1057516090 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516091 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1057516092 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS1057516093 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516094 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1057516095 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516096 |
KCNQ2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, KCNQ2-related disorder |
| RS1057516097 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1057516098 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516099 |
KCNQ2
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1057516100 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516101 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516103 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057516104 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1057516105 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1057516106 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1057516111 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1057516115 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1057516121 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1057516123 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1057516127 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057516128 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057516129 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057516130 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057516132 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057516133 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057516134 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057516135 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |